Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects
The plasminogen activator inhibitor-1 4G/5G and tissue plasminogen activator Alu-repeat insertion/deletion polymorphisms might be genetic determinations of increased or decreased of their plasma activities. The aim of this study was to investigate the association of plasminogen activator inhibitor-1...
Saved in:
Main Authors: | Al-Hamodi, Z.H., Saif-Ali, R., Ismail, I.S., Ahmed, K.A., Muniandy, S. |
---|---|
Format: | Article |
Published: |
2012
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/3156/ http://www.ncbi.nlm.nih.gov/pubmed/22573918 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
by: Al-Hamodi, Z., et al.
Published: (2011) -
Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in malaysian subjects
by: Al-Hamodi, Z., et al.
Published: (2012) -
The association between serum and tear plasminogen activator inhibitor-1 and tissue plasminogen activator in patients with diabetic retinopathy / Nurbadriah Jasmiad
by: Jasmiad, Nurbadriah
Published: (2021) -
The 4717C > G polymorphism in periplakin modulates sensitivity to EGFR inhibitors
by: Lee, Hui Mei, et al.
Published: (2019) -
Association of DPP4 gene polymorphisms with type 2 diabetes mellitus in Malaysian subjects
by: Ahmed, R.H., et al.
Published: (2016)